After attending the Health Equity in Clinical Trials Congress, I spent time reflecting on the contributions of the remarkable individuals who participated in the conference. Among them were leaders and Heads of Diversity & Inclusion in Clinical Trials from some of the world’s largest pharmaceutical companies like GSK, Boehringer Ingelheim, Pfizer, Eli Lilly, Merck and Takeda to name a few. The panel discussions were riveting, and the participants provided exceptionally insightful opinions and views.
